Substance or medication-induced depressive disorder

Jump to navigation Jump to search

Clinical Depression Microchapters

Home

Patient Information

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Clinical Depression from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Substance or medication-induced depressive disorder On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Substance or medication-induced depressive disorder

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Substance or medication-induced depressive disorder

CDC on Substance or medication-induced depressive disorder

Substance or medication-induced depressive disorder in the news

Blogs on Substance or medication-induced depressive disorder

Directions to Hospitals Treating Clinical depression

Risk calculators and risk factors for Substance or medication-induced depressive disorder

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Substance-induced depressive disorder is characterized by a persistent depressed mood that developed during or after substance intoxication or withdrawal or after exposure to a medication.

Differential Diagnosis

Substance- or medication-induced depression must be differentiated from:

Epidemiology and Demographics

Prevalence

The prevalence of substance or medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.[1]

Risk Factors

Risk factors for the development of substance- or medication-induced depressive disorder include:

==Diagnostic Criteria== Sai Rohit Reddy, M.B.B.S.

DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder [1]

  • A. A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by depressed mood or markedly diminished interest or pleasure in all, or almost all, activities.

AND

  • B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2):
  • 1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
  • 2. The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

  • C. The disturbance is not better explained by a depressive disorder that is not substance/medication-induced. Such evidence of an independent depressive disorder could include the following:
  • The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes).

AND

  • D. The disturbance does not occur exclusively during the course of a delirium.

AND

  • E. The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning.

Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention.

References

  1. 1.0 1.1 1.2 1.3 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.


Template:WikiDoc Sources